WEIBEN PHARMACEUTICAL
Weiben Pharmaceutical focuses on the research and development of new drugs, mainly small-molecule targeted drugs in the tumor field, and develops innovative drugs with targets such as c-myc and CaMKIIγ.
WEIBEN PHARMACEUTICAL
Industry:
Biotechnology Pharmaceutical Therapeutics
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.webenpharma.com
Status:
Active
Contact:
86-571-58122058
Email Addresses:
[email protected]
Technology used in webpage:
SPF Nginx Java EE Alibaba HiChina DNS Tencent QQ Mail Nginx 1.13
Official Site Inspections
http://www.webenpharma.com
- Host name: 47.98.218.122
- IP address: 47.98.218.122
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Weiben Pharmaceutical"
杭州卫本药业有限公司_Webnpharma Pharmaceuticals
WebenPharma is a biopharmaceutical company focusing on the discovery, development and commercialization of targeted small molecule drugs to treat cancer patients. Our programs …See details»
杭州卫本药业有限公司_Webnpharma Pharmaceuticals
Contact us. 1180 Binan Road,HangZhou,China Tel: +86-571-58122058. Email:[email protected]See details»
WebenPharma - Company Profile - Tracxn
Nov 27, 2024 WebenPharma - Developer of small-molecular therapeutics for cancer treatment. Raised funding from 1 investor. WebenPharma has 2859 competitors.See details»
杭州卫本药业有限公司 - webenpharma.com
Webenpharma是着眼于发现的生物制药公司，开发和商业化的小分子药物靶向治疗癌症患者。我们的计划专门针对小分子化合物，这些药物可能是第一类药物，很少或根本没有竞争，或显示出 …See details»
WebenPharma - Overview, News & Similar companies
View WebenPharma (www.webenpharma.com) location in Zhejiang, China , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
www.webenpharma.net
Contact us. 1180 Binan Road,HangZhou,China Tel: +86-571-58122058. Email:[email protected]See details»
WebenPharma - Overview - aiHit
WebenPharma is a biopharmaceutical company focusing on the discovery, development and commercialization of targeted small molecule drugs to treat cancer patients. Our programs …See details»
Webnpharma Pharmaceuticals - webenpharma.net
1180 Binan Road, Hangzhou China. Tel: +86-571-58122058. Email: [email protected]See details»
WebenPharma - Raised Funding from 1 investor - Tracxn
Developer of small-molecular therapeutics for cancer treatment. Last updated: March 7, 2024 Claim Profile Suggest EditsSee details»
卫本药业-动脉网 - vbdata.cn
Mar 7, 2017 杭州卫本药业有限公司是着眼于发现的生物制药公司，开发和商业化的小分子药物靶向治疗癌症患者。杭州卫本药业有限公司的计划专门针对小分子化合物，这些药物可能是第一 …See details»
Hangzhou Weiben Pharmaceutical Co. Ltd. - synapse.zhihuiya.com
了解Hangzhou Weiben Pharmaceutical Co. Ltd. (杭州卫本药业有限公司)公司的药物管线，治疗领域，技术平台，以及它的2项临床试验，疾病领域:肿瘤，血液及淋巴系统疾病，内分泌与代谢 …See details»
webenpharma.org
Webenpharma.orgSee details»
杭州卫本药业有限公司 - webenpharma.com
联系方式. 浙江省杭州市滨江区滨安路1180号 电话: +86-571-58122058 邮箱:[email protected]See details»
Weiben Pharmaceutical - Crunchbase Company Profile & Funding
Weiben Pharmaceutical focuses on the research and development of new drugs, mainly small-molecule targeted drugs in the tumor field, and develops innovative drugs with targets such as …See details»
Webnpharma Pharmaceuticals - webenpharma.net
We have a number of partnerships with Zhejiang University and local pharmaceutical companies.See details»
杭州卫本药业有限公司_Webnpharma Pharmaceuticals
WB001 is an oral small-molecule compound and has demonstrated excellent efficacy against human pancreatic, lung and stomach cancer cell lines in Xenograft mouse models. It is in pre …See details»
Webnpharma Pharmaceuticals - webenpharma.net
Medicinal Chemists: BS/MS in chemistry with 2-6 years' experience. Analytical Chemists: BS/MS in chemistry with 2-6 years' experienceSee details»
Webnpharma Pharmaceuticals - webenpharma.net
WB001 is an oral small-molecule compound and has demonstrated excellent efficacy against human pancreatic, lung and stomach cancer cell lines in Xenograft mouse models. It is in pre …See details»
Weben Pharma News - LARVOL Sigma
News linked to Weben Pharma. WB100 / Weben Pharma Journal: A Selective Small-Molecule c-Myc Degrader Potently Regresses Lethal c-Myc Overexpressing Tumors. (Pubmed Central) - …See details»
杭州卫本药业有限公司_Webnpharma Pharmaceuticals
We have a number of partnerships with Zhejiang University and local pharmaceutical companies.See details»